Ipamorelin

A selective growth hormone secretagogue that stimulates natural GH release without a cortisol or prolactin spike. One of the cleanest GH-stimulating compounds in the research literature.

Selectively binds the ghrelin receptor to stimulate a GH pulse from the pituitary, with no effect on cortisol, prolactin or ACTH at studied concentrations.

Your pituitary releases growth hormone in pulses naturally. Ipamorelin nudges those pulses to be larger and more frequent without the hormonal side effects of less selective compounds. Clean, selective and extensively studied.

• Serum GH pulse amplitude
• IGF-1 levels
• Cortisol and prolactin baselines
• Lean mass and body composition
• Sleep architecture
• Bone density markers

• GH optimisation
• Lean muscle support
• Fat reduction
• Sleep quality improvement
• Anti-aging applications
• Bone density

Developed by Novo Nordisk as a selective growth hormone secretagogue, distinguished from earlier secretagogues by its lack of cortisol and prolactin elevation.

Men and women 30-65 focused on GH optimisation, lean muscle, fat loss, sleep quality and anti-aging. Typically stacked with CJC-1295.

• Reconstitute with bacteriostatic water down the vial wall.
• Swirl gently until clear, never shake.
• Store lyophilised at -20C.
• Reconstituted solution stable up to 28 days at 4C.
• Timing near natural GH pulses is common in protocols.

• Selective for GH release, no cortisol or prolactin spike at studied doses.
• Short half-life supports pulsatile protocol design.
• Commonly stacked with a GHRH analogue for amplified pulse.
• Effects are downstream of natural pituitary function.